References
- Powderly WG. Cryptococcal meningitis and AIDS. Clin Infect Dis 1993; 17(5): 837–42
- Wheat J. Histoplasmosis and coccidioidomycosis in individuals with AIDS: a clinical review. Infect Dis Clin North Am 1994; 8(2): 467–82
- Ennis DM, Saag MS. Cryptococcal meningitis in AIDS. Hosp Pract (Off Ed) 1993; 28(10): 99–112
- Diamond RD. Cryptococcus neoformans. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practices of infectious diseases. 4th ed. New York: Churchill Livingstone 1995; 2331–9
- Saag MS. Editorial response: clinical and host differences between infections with the two varieties of Cryptococcus neoformans. Clin Infect Dis 1995; 21(1): 35–6
- Pinner RW, Hajjeh RA, Powderly WG. Prospects for preventing cryptococcosis in persons infected with human immunodeficiency virus. Clin Infect Dis 1995; 21(Suppl 1): S103–7
- White MH, Armstrong D. Cryptococcosis. Infect Dis Clin North Am 1994; 8(2): 383–98
- Meyohas MC, Roux P, Bollens D, et al. Pulmonary cryptococcosis: localized and disseminated infections in 27 patients with AIDS. Clin Infect Dis 1995; 21(3): 628–33
- Mulanovich VE, Dismukes WE, Markowitz N. Cryptococcal empyema: case report and review. Clin Infect Dis 1995; 20(5): 1396–8
- Cameron ML, Bartlett JA, Gallis HA, et al. Manifestations of pulmonary cryptococcosis in patients with acquired immunodeficiency syndrome. Rev Infect Dis 1991; 13(1): 64–7
- Chuck SL, Sande MA. Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome. N Engl J Med 1989; 321(12): 794–9
- Popovich MJ, Arthur RH, Helmer E. CT of intracranial cryptococcosis. AJNR Am J Neuroradiol 1990; 11(1): 139–42
- Mathews VP, Alo PL, Glass JD, et al. AIDS-related CNS cryptococcosis: radiologic-pathologic correlation. AJNR Am J Neuroradiol 1992; 13(5): 1477–86
- Goldschmidt RH, Dong BJ. Treatment of AIDS and HIV-related conditions: 1995. J Am Board Fam Pract 1995; 8(2): 139–162
- Saag MS, Powderly WG, Cloud GA, et al. Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. N Engl J Med 1992; 326(2): 83–9
- Larsen RA, Leal MA, Chan LS. Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS: a randomized trial. Ann Intern Med 1990; 113(3): 183–7
- de Gans J, Portegies P, Hessens G, et al. Itraconazole compared with amphotericin B plus flucytosine in AIDS patients with cryptococcal meningitis. AIDS 1992; 6(2): 185–90
- Powderly WG, Cloud GA, Dismukes WE, et al. Measurement of cryptococcal antigen in serum and cerebrospinal fluid: value in the management of AlDS-associated cryptococcal meningitis. Clin Infect Dis 1994; 18(5): 789–92
- Bozzette SA, Larsen RA, Chiu J, et al. A placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. N Engl J Med 1991; 324(9): 580–4
- Powderly WG, Saag MS, Cloud GA, et al. A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. N Engl J Med 1992; 326(12): 793–8
- Van Der Horst C. Fluconazole prophylaxis for Cryptococcus neoformans: guidelines for primary and secondary prophylaxis. HIV Newsline 1995; 1: 20–3
- Quagliarello VJ, Viscoli C, Horwitz RI. Primary prevention of cryptococcal meningitis by fluconazole in HIV-infected patients. Lancet 1995; 345(8949): 548–52
- Powderly WG, Finkelstein D, Feinberg J, et al. A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection. N Engl J Med 1995; 332(11): 700–5
- Bullock WE. Histoplasma capsulatum. In: Mandell et al, eds,4 pp 2340–53
- Hajjeh RA. Disseminated histoplasmosis in persons infected with human immunodeficiency virus. Clin Infect Dis 1995; 21(Suppl 1): S108–10
- Sarosi GA, Johnson PC. Disseminated histoplasmosis in patients infected with human immunodeficiency virus. Clin Infect Dis 1992; 14(Suppl 1): S60–7
- Wheat LJ, Connolly-Stringfield PA, Baker RL, et al. Disseminated histoplasmosis in the acquired immune deficiency syndrome: clinical findings, diagnosis and treatment, and review of the literature. Medicine (Baltimore) 1990; 69(6): 361–74
- Eidbo J, Sanchez RL, Tschen JA, et al. Cutaneous manifestations of histoplasmosis in the acquired immunodeficiency syndrome. Am J Surg Pathol 1993; 17(2): 110–6
- Saag MS. Histoplasmosis. In: Sande MA, Volberding PA, eds. Medical management of AIDS. 4th ed. Philadelphia: Saunders, 1995; 450–9
- Wheat LJ, Kohler RB, Tewari RP. Diagnosis of disseminated histoplasmosis by detection of Histoplasma capsulatum antigen in serum and urine specimens. N Engl J Med 1986; 314(2): 83–8
- Wheat LJ, Connolly-Stringfield P, Blair R, et al. Effect of successful treatment with amphotericin B on Histoplasma capsulatum variety capsulatum polysaccharide antigen levels in patients with AIDS and histoplasmosis. Am J Med 1992; 92(2): 153–60
- Wheat LJ, Connolly-Stringfield P, Blair R, et al. Histoplasmosis relapse in patients with AIDS: detection using Histoplasma capsulatum variety capsulatum antigen levels. Ann Intern Med 1991; 115(12): 936–41
- Wheat J, Hafner R, Korzun AH, et al. Itraconazole treatment of disseminated histoplasmosis in patients with the acquired immunodeficiency syndrome. Am J Med 1995; 98(4): 336–42
- Wheat J, Hafner R, Wulfsohn M, et al. Prevention of relapse of histoplasmosis with itraconazole in patients with the acquired immunodeficiency syndrome. Ann Intern Med 1993; 118(8): 610–6